{"id":898554,"date":"2025-10-21T19:09:02","date_gmt":"2025-10-21T23:09:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/"},"modified":"2025-10-21T19:09:02","modified_gmt":"2025-10-21T23:09:02","slug":"biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/","title":{"rendered":"Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series"},"content":{"rendered":"
\n

SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (\u201cBiomea\u201d) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi\u2019s SMID Biotech C-Suite Fireside Chat Series on Thursday, October 23, 2025, at 8:00 a.m. Pacific Time \/ 11:00 a.m. Eastern Time.<\/p>\n

A live audio webcast of the discussion will be available here<\/u><\/a> or by visiting the Investors & Media section of Biomea\u2019s website at https:\/\/investors.biomeafusion.com\/news-events\/events<\/u><\/a>. A replay of the webcast will be available following the live event.<\/p>\n

\n About Biomea Fusion<\/strong>
\n
Biomea Fusion is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecule therapies, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic disorders, a global health challenge affecting nearly half of Americans and one-fifth of the world\u2019s population. Biomea\u2019s mission is to deliver transformative treatments that restore health for patients living with diabetes, obesity, and related conditions. We aim to cure.<\/p>\n

Visit us at biomeafusion.com and follow us on\u00a0LinkedIn<\/u><\/a>, X<\/u><\/a> and\u00a0Facebook<\/u><\/a>.<\/p>\n

\n Contact:<\/strong>
\n
Meichiel Jennifer Weiss
Sr. Director of Investor Relations and Corporate Development
ir@biomeafusion.com<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (\u201cBiomea\u201d) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi\u2019s SMID Biotech C-Suite Fireside Chat Series on Thursday, October 23, 2025, at 8:00 a.m. Pacific Time \/ 11:00 a.m. Eastern Time. A live audio webcast of the discussion will be available here or by visiting the Investors & Media section of Biomea\u2019s website at https:\/\/investors.biomeafusion.com\/news-events\/events. A replay of the webcast will be available following the live event. About Biomea Fusion Biomea Fusion is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecule therapies, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic … <\/p>\n

Continue reading “Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-898554","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBiomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (\u201cBiomea\u201d) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi\u2019s SMID Biotech C-Suite Fireside Chat Series on Thursday, October 23, 2025, at 8:00 a.m. Pacific Time \/ 11:00 a.m. Eastern Time. A live audio webcast of the discussion will be available here or by visiting the Investors & Media section of Biomea\u2019s website at https:\/\/investors.biomeafusion.com\/news-events\/events. A replay of the webcast will be available following the live event. About Biomea Fusion Biomea Fusion is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecule therapies, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic … Continue reading "Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-21T23:09:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series\",\"datePublished\":\"2025-10-21T23:09:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/\"},\"wordCount\":202,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/\",\"name\":\"Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=\",\"datePublished\":\"2025-10-21T23:09:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/","og_locale":"en_US","og_type":"article","og_title":"Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series - Market Newsdesk","og_description":"SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (\u201cBiomea\u201d) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi\u2019s SMID Biotech C-Suite Fireside Chat Series on Thursday, October 23, 2025, at 8:00 a.m. Pacific Time \/ 11:00 a.m. Eastern Time. A live audio webcast of the discussion will be available here or by visiting the Investors & Media section of Biomea\u2019s website at https:\/\/investors.biomeafusion.com\/news-events\/events. A replay of the webcast will be available following the live event. About Biomea Fusion Biomea Fusion is a clinical-stage diabetes and obesity medicines company focused on the development of its oral small molecule therapies, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic … Continue reading \"Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-21T23:09:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series","datePublished":"2025-10-21T23:09:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/"},"wordCount":202,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/","name":"Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=","datePublished":"2025-10-21T23:09:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTczNiM3MjA4MDU0IzIyMDg1NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biomea-fusion-to-participate-in-citis-smid-biotech-c-suite-fireside-chat-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/898554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=898554"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/898554\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=898554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=898554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=898554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}